Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

Name: Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024
SKU: MED-AMB02530
Price: 50.00 USD
Availability: InStock

$50.00

Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024 This Current Concepts course will highlight the recent developments regarding diagnosis as well as medical and surgical therapy of common eye diseases. The participant should get a comprehensive review of the most current concepts in the management of ophthalmology by experts across the breadth of the field.

content : 10 videos + 31 pdfs, size: 12.2 GB

Guaranteed Safe Checkout

VISA mastercard AMERICAN
EXPRESS DISCOVER PayPal

⚙️ 24/7 support available

🔒 Payments are encrypted and 100% secure

Recommended medical resources for your specialty.

Johns Hopkins Wilmer Eye Institute’s 40th Annual Current Concepts in Ophthalmology 2024

$50.00

MER Primary Care Conferences Internal Medicine for Primary Care Derm ENT Ophth Mar 20-22, 2026

1 × MER Primary Care Conferences Internal Medicine for Primary Care Derm ENT Ophth Mar 20-22, 2026

Establishing a Wetlab for Cataract Surgery Training (Original PDF from Publisher)

1 × Establishing a Wetlab for Cataract Surgery Training (Original PDF from Publisher)

American Society of Ophthalmic Administrators Annual Meeting On Demand 2025

1 × American Society of Ophthalmic Administrators Annual Meeting On Demand 2025

$50.00

Decision Making in Ophthalmology: An Algorithmic Approach, 3rd edition (EPUB)

1 × Decision Making in Ophthalmology: An Algorithmic Approach, 3rd edition (EPUB)

Carefully selected courses and references to support your clinical practice.

Description

Date & Location

Monday, March 18, 2024, 7:00 AM – Friday, March 22, 2024, 7:00 PM, Vail Marriott, Vail, CO

Target Audience

Specialties – Ophthalmology

content : 10 videos + 31 pdfs, size: 12.2 GB

Overview

For example, clinical trials and other evidence in the peer-reviewed literature over the past few years have changed the approach to managing cataract including IOL technology and femtosecond laser cataract surgery, corneal disease including dry eye disease, keratoplasty, and collagen cross linking, glaucoma and minimally invasive glaucoma surgical devices, as well as diabetic retinopathy, macular degeneration, and retinal vein occlusions. Furthermore, the role of optical coherence tomography (OCT) and other imaging advances are expanding the understanding of the anatomy of the anterior and posterior segment of the eye.

This course will address the ongoing pattern of registrants with repeat requests for demonstrations of the latest surgical techniques and medical therapies, questions regarding practice management issues and clarification of legislative updates. There is a demand for expert education of new techniques and medical therapies as well as the need for elucidation of associated clinical trials, and this course provides extensive coverage of that.

Objectives

Integrate prescribed medical and surgical treatment options into everyday practice, including uveitis, oculoplastic and ocular oncology.
Assess the perioperative use of antibiotic and anti-inflammatory agents in patients undergoing eye surgery.
Formulate current and advanced medical and surgical treatment strategies as well as imaging with corresponding ocular conditions, including: glaucoma, retina, anterior segment including “dry eye”, uveitis, refractive surgery and laser assisted cataract and corneal transplant surgery.
Discuss new medical techniques, therapies and relevant clinical trials in dry eye, refractive surgery, cornea, glaucoma, and retina, including diabetic retinopathy, macular degeneration, and retinal vein occlusion.
Assess the latest developments for the management of pediatric ophthalmology and strabismus conditions.
Describe unique considerations for cataract surgery in patients with comorbid glaucoma.

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Anterior Segment (Cornea) -CHAIR.pdf
Anterior Segment Challenges and Academic Ophthalmology – MODERATOR.pdf
Antibody Drug Conjugate- What are They and What Does An Ophthalmologist Need to Know About Them.pdf
Artificial Intelligence and Retinal Imaging.pdf
Blepharoplasty Basics.pdf
Cataract Surgery – CHAIR.pdf
CCV-Program-March-15-2024.pdf
Corneal Neurotization.pdf
Corticosteroids for Retinal Diseases- When Are They Considered; How Are They Delivered.pdf
Current Management of Keratoconus- Crosslinking, Lenses, Surgery.pdf
DMEK Complications.pdf
Endothelial Graft Inserters.pdf
Faricimab and High-Dose Aflibercept- Newest Anti-VEGF Agents on the Block.pdf
Illustrative Cases.pdf
Managing Refractive Error.pdf
March 18 Cataract Surgery.mp4
March 18 Managing Refractive Error – Anterior Segment.mp4
March 19 Anterior Segment-Cornea.mp4
March 19 Other Anterior Segment Topics.mp4
March 20 Glaucoma.mp4
March 20 Retina.mp4
March 21 Retina from the Comprehensive Ophthalmologist.mp4
March 21 Uveitis.mp4
March 22 Oculoplastics and Neuro-ophthalmology.mp4
March 22 Oculoplastics and Orbit.mp4
Non-surgical Oculoplastics Rejuvenation.pdf
Objective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology.pdf
Oral Corticosteroids and Immunosuppression-How to Do It.pdf
Other Anterior Segment Topics -CHAIR.pdf
Patient Predictors of Advanced Technology Intraocular Lens Utilization.pdf
Port Delivery Systems for Retinal Diseases- Advantages and Safety.pdf
Rational Use of Topical Corticosteroids.pdf
Reducing Waste in Cataract Surgery- Quantifying the Problem and Implementing Solutions.pdf
Regional Variability in Endothelial Cell Loss after Intraocular Surgery.pdf
Severe Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy.pdf
Starting DMEK.pdf
Update On Office Treatment of the Cornea Surface- Basement Membrane Opacities, Nodules, and Band Keratopathy.pdf
Uveitic Glaucoma.pdf
What’s New in Managing Double Vision in Thyroid Eye Disease..pdf
When to Perform DSAEK vs. DMEK.pdf
Wilmer Eye Institute Turns 100- Looking Back on the Last Century of Ophthalmology.pdf

*Detail:

Monday, March 18, 2024

Accreditation Information and Agenda
7:00AM – 7:10AM

Cataract Surgery – CHAIR
7:00AM – 10:00AM
Yassine Daoud, MD

Cataract Surgery – CHAIR
7:00AM – 10:00AM
Shameema Sikder, MD

Interesting and Complex Cases
7:00AM – 7:20AM
Yassine Daoud, MD

IOL Support in Absence of Capsular Support
7:20AM – 7:40AM
Yassine Daoud, MD

Cataract Surgery in Eyes Post-Vitrectomy or Other Ocular Surgeries
7:40AM – 8:00AM
Shameema Sikder, MD

Iris-Sutured IOL Repairs
8:00AM – 8:20AM
Yassine Daoud, MD

Corneal Neurotization
8:40AM – 9:00AM
Shameema Sikder, MD

AI Driven Performance Assessment Tools for Cataract Surgery
9:00AM – 9:40AM
Shameema Sikder, MD

Case Discussions
9:40AM – 10:00AM
Yassine Daoud, MD

Managing Post- Cataract Surgery Inflammation
5:00PM – 5:20PM
Yassine Daoud, MD

Managing Refractive Error
5:00PM – 6:00PM
Christina R Prescott, MD, PhD

Managing Refractive Error – MODERATOR
5:00PM – 6:00PM
Yassine Daoud, MD

IOL Exchange vs LASIK/PRK for Refractive Surprise after Cataract Surgery
5:20PM – 5:40PM
Yassine Daoud, MD

Questions and Discussion
5:40PM – 6:00PM
Christina R Prescott, MD, PhD

Questions and Discussion
5:40PM – 6:00PM
Yassine Daoud, MD

Anterior Segment Challenges and Academic Ophthalmology – MODERATOR
6:00PM – 7:00PM
Christina R Prescott, MD, PhD

Anterior Segment Challenges and Academic Ophthalmology – MODERATOR
6:00PM – 7:00PM
Shameema Sikder, MD

Current Management of Keratoconus: Crosslinking, Lenses, Surgery
6:00PM – 6:15PM
Michael Raizman, MD

Wilmer Eye Institute Turns 100: Looking Back on the Last Century of Ophthalmology
6:15PM – 6:30PM
Peter McDonnell, MD

Update On Office Treatment of the Cornea Surface: Basement Membrane Opacities, Nodules, and Band Keratopathy
6:30PM – 6:45PM
Michael Raizman, MD

Questions and Discussion
6:45PM – 7:00PM
Christina R Prescott, MD, PhD

Tuesday, March 19, 2024

Anterior Segment (Cornea) -CHAIR
7:00AM – 10:00AM
Christina R Prescott, MD, PhD

Anterior Segment (Cornea) -CHAIR
7:00AM – 10:00AM
Mark A Terry, MD

Regional Variability in Endothelial Cell Loss after Intraocular Surgery
7:00AM – 7:20AM
Christina R Prescott, MD, PhD

Starting DMEK
7:20AM – 7:40AM
Mark A Terry, MD

Looking Forward: Challenges and Opportunities for Ophthalmology in the Next Decade
7:40AM – 8:00AM
Peter McDonnell, MD

Patient Predictors of Advanced Technology Intraocular Lens Utilization
8:00AM – 8:20AM
Christina R Prescott, MD, PhD

DMEK Complications
8:40AM – 9:00AM
Mark A Terry, MD

Ocular Surface Complications from Systemic Medications
9:00AM – 9:20AM
Shameema Sikder, MD

When to Perform DSAEK vs. DMEK
9:20AM – 9:40AM
Mark A Terry, MD

Questions and Discussions
9:40AM – 10:00AM

Endothelial Graft Inserters
5:00PM – 5:20PM
Mark A Terry, MD

Other Anterior Segment Topics -CHAIR
5:00PM – 7:00PM
Shameema Sikder, MD

Other Anterior Segment Topics -CHAIR
5:00PM – 7:00PM
Christina R Prescott, MD, PhD

Keratoprosthesis: Update
5:20PM – 5:40PM
Yassine Daoud, MD

Reducing Waste in Cataract Surgery: Quantifying the Problem and Implementing Solutions
5:40PM – 6:00PM
Christina R Prescott, MD, PhD

Role of Surgical Labs in Ophthalmic Education
6:00PM – 6:20PM
Shameema Sikder, MD

Objective and Subjective Outcomes of Extended Depth of Focus Intraocular Lenses in Patients with Ocular Pathology
6:20PM – 6:40PM
Christina R Prescott, MD, PhD

Questions and Discussions
6:40PM – 7:00PM
Shameema Sikder, MD

Wednesday, March 20, 2024

Glaucoma – CHAIR
7:00AM – 10:00AM
Thomas V Johnson III, MD, PhD

Glaucoma – CHAIR
7:00AM – 10:00AM
Pradeep Ramulu, MD, PhD

Monitoring Glaucoma from Home
7:00AM – 7:15AM
Thomas V Johnson III, MD, PhD

Trabecular MIGS
7:15AM – 7:30AM
Jella A An, MD, MBA

MicroPulse Transscleral Laser Therapy
7:30AM – 7:45AM
Jella A An, MD, MBA

Update on Angle Closure
7:45AM – 8:00AM
Pradeep Ramulu, MD, PhD

Questions and Answers
8:00AM – 8:10AM
Pradeep Ramulu, MD, PhD

Questions and Answers
8:00AM – 8:10AM
Jella A An, MD, MBA

Questions and Answers
8:00AM – 8:10AM
Thomas V Johnson III, MD, PhD

Cataract Surgery in the Glaucoma Patient- When is Phaco Enough?
8:25AM – 8:45AM
Pradeep Ramulu, MD, PhD

Update on Neuroprotection for Glaucoma: The Time Has Come
8:45AM – 9:05AM
Thomas V Johnson III, MD, PhD

Retinal Ganglion Cell Regeneration: Science Fiction or Scientific Possibility?
9:05AM – 9:20AM
Thomas V Johnson III, MD, PhD

Visual Fields – New tests, strategies, and tips for interpretation
9:20AM – 9:40AM
Pradeep Ramulu, MD, PhD

Questions and Answers
9:40AM – 9:45AM
Thomas V Johnson III, MD, PhD

Questions and Answers
9:40AM – 9:45AM
Pradeep Ramulu, MD, PhD

Potential Impact of AI Chatbots: For Editors, Authors, and Readers of Peer-Reviewed Ophthalmic Literature
9:45AM – 10:00AM
Neil Bressler, MD

Common Misperceptions Regarding Management of Diabetic Macular Edema, including Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
4:20PM – 4:40PM
Neil Bressler, MD

Retina: Chair
4:20PM – 7:00PM
Jun Kong, MD, PhD

Retina: Chair
4:20PM – 7:00PM
Christina Y. Weng, MD, MBA

Home OCT-Guided Treatment versus Treat and Extend for the Management of Neovascular AMD
4:40PM – 5:00PM
Christina Y. Weng, MD, MBA

Current Management of Proliferative Diabetic Retinopathy
5:00PM – 5:20PM
Neil Bressler, MD

Port Delivery Systems for Retinal Diseases: Advantages and Safety
5:20PM – 5:40PM
Christina Y. Weng, MD, MBA

Diabetic Macular Edema: Prophylaxis vs Treat when VA Loss
5:40PM – 6:00PM
Neil Bressler, MD

Artificial Intelligence and Retinal Imaging
6:00PM – 6:20PM
Jun Kong, MD, PhD

Ultrawide Field Imaging to Manage Diabetic Retinopathy Artificial Intelligence and Retinal Imaging
6:20PM – 6:40PM
Neil Bressler, MD

Questions and Discussion
6:40PM – 7:00PM
Christina Y. Weng, MD, MBA

Thursday, March 21, 2024

Corticosteroids for Retinal Diseases: When Are They Considered; How Are They Delivered
7:00AM – 7:20AM
Christina Y. Weng, MD, MBA

Retina for The Comprehensive Ophthalmologist: Chair
7:00AM – 11:30AM
Susan Bressler, MD

Retina for The Comprehensive Ophthalmologist: Chair
7:00AM – 11:30AM
Christina Y. Weng, MD, MBA

Biosimilars: They’ve Arrived in Ophthalmology
7:20AM – 7:40AM
Susan Bressler, MD

Management of Symptomatic Epiretinal Membranes and DRCR Retina Network’s Protocol AM
7:40AM – 8:00AM
Christina Y. Weng, MD, MBA

Faricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block
8:00AM – 8:20AM
Susan Bressler, MD

Faricimab and High-Dose Aflibercept: Newest Anti-VEGF Agents on the Block
8:00AM – 8:20AM
Christina Y. Weng, MD, MBA

Managing the Patient with Geographic Atrophy
8:40AM – 9:00AM
Susan Bressler, MD

Severe Intraocular Inflammation with Newer Intravitreal Agents for Neovascular AMD or Geographic Atrophy
9:00AM – 9:20AM
Jun Kong, MD, PhD

Falls in Ophthalmology: A Potentially Overlooked Common Problem
9:20AM – 9:40AM
Susan Bressler, MD

Questions and Discussion
9:40AM – 10:00AM
Susan Bressler, MD

Questions and Discussion
9:40AM – 10:00AM
Christina Y. Weng, MD, MBA

Imaging Workshop: A Picture is Worth A Thousand Exams
10:15AM – 11:30AM
Susan Bressler, MD

Imaging Workshop: A Picture is Worth A Thousand Exams
10:15AM – 11:30AM
Jun Kong, MD, PhD

Rational Use of Topical Corticosteroids
5:00PM – 5:20PM
Meghan Berkenstock, MD

Uveitis -CHAIR
5:00PM – 7:00PM
Douglas A Jabs, MD, MBA

Uveitis -CHAIR
5:00PM – 7:00PM
Meghan Berkenstock, MD

Oral Corticosteroids and Immunosuppression:How to Do It
5:20PM – 5:40PM
Douglas A Jabs, MD, MBA

Antibody Drug Conjugate: What are They and What Does An Ophthalmologist Need to Know About Them
5:40PM – 6:00PM
Meghan Berkenstock, MD

Uveitic Glaucoma
6:00PM – 6:20PM
Douglas A Jabs, MD, MBA

Illustrative Cases
6:20PM – 7:00PM
Meghan Berkenstock, MD

Illustrative Cases
6:20PM – 7:00PM
Douglas A Jabs, MD, MBA

Friday, March 22, 2024

Lumps and Bumps: Management 101 for the Comprehensive Ophthalmologist
7:00AM – 7:20AM
Sara T Wester, MD

Oculoplastics and Orbit: Chair
7:00AM – 10:00AM
Sophie Liao, MD

Oculoplastics and Orbit: Chair
7:00AM – 10:00AM
Nicholas Mahoney, MD

Update on the Management of Eyelid Cancers
7:20AM – 7:40AM
Ashley Campbell, MD

Non-surgical Oculoplastics Rejuvenation
7:40AM – 8:00AM
Sophie Liao, MD

Thyroid Eye Disease Update: Medical and Surgical Innovations
8:00AM – 8:20AM
Nicholas Mahoney, MD

Treating the Tearing Patient
8:40AM – 9:00AM
Sara T Wester, MD

Blepharoplasty Basics
9:00AM – 9:20AM
Sophie Liao, MD

Complicated Cosmetic Cases
9:20AM – 10:00AM
Sara T Wester, MD

Complicated Cosmetic Cases
9:20AM – 10:00AM
Sophie Liao, MD

Complicated Cosmetic Cases
9:20AM – 10:00AM
Nicholas Mahoney, MD

Complicated Cosmetic Cases
9:20AM – 10:00AM
Ashley Campbell, MD

Imaging in Oculoplastics: Fractures, Tumors, Surgical Applications
5:00PM – 5:20PM
Nicholas Mahoney, MD

Oculoplastics and Neuro-ophthalmology – CHAIR
5:00PM – 7:00PM
Andrew Carey, MD

Oculoplastics and Neuro-ophthalmology – CHAIR
5:00PM – 7:00PM
Nicholas Mahoney, MD

Acute Periorbital Infections: What Do All Ophthalmologists Need to Know
5:20PM – 5:40PM
Ashley Campbell, MD

Neurosurgical Approaches to the Orbit
5:40PM – 6:00PM
Nicholas Mahoney, MD

What’s New in Managing Double Vision in Thyroid Eye Disease?
6:00PM – 6:20PM
Andrew Carey, MD

Advanced OCT Interpretation in Neuro-ophthalmology: Beyond Average RNFL Thickness
6:20PM – 6:40PM
Andrew Carey, MD

Questions and Answers
6:40PM – 6:50PM
Andrew Carey, MD

Questions and Answers
6:40PM – 6:50PM
Nicholas Mahoney, MD

Closing Remarks and Adjourn
6:50PM – 7:00PM
Neil Bressler, MD